These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3047341)

  • 21. Prognostic implications of the proliferative potential of low-grade astrocytomas.
    Hoshino T; Rodriguez LA; Cho KG; Lee KS; Wilson CB; Edwards MS; Levin VA; Davis RL
    J Neurosurg; 1988 Dec; 69(6):839-42. PubMed ID: 3193189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The ocular effects of intracarotid bromodeoxyuridine and radiation therapy in the treatment of malignant glioma.
    Vander JF; Kincaid MC; Hegarty TJ; Page M; Averill D; Junck L; Greenberg HS
    Ophthalmology; 1990 Mar; 97(3):352-7. PubMed ID: 2186331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of CT contrast enhancement and BUDR labeling indices in moderately and highly anaplastic astrocytomas of the cerebral hemispheres.
    McDermott MW; Krouwer HG; Asai A; Ito S; Hoshino T; Prados MD
    Can J Neurol Sci; 1992 Feb; 19(1):34-9. PubMed ID: 1562905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase I-II evaluation of intra-arterial diaziquone for recurrent malignant astrocytomas.
    Greenberg HS; Ensminger WD; Layton PB; Gebarski S; Meyer M; Chaffee B; Bender JF; Grillo-Lopez AJ
    Cancer Treat Rep; 1986 Mar; 70(3):353-7. PubMed ID: 3006913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Continuous intravenous infusions of bromodeoxyuridine as a clinical radiosensitizer.
    Kinsella TJ; Mitchell JB; Russo A; Aiken M; Morstyn G; Hsu SM; Rowland J; Glatstein E
    J Clin Oncol; 1984 Oct; 2(10):1144-50. PubMed ID: 6092551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In situ cell kinetics studies on human neuroectodermal tumors with bromodeoxyuridine labeling.
    Hoshino T; Nagashima T; Murovic JA; Wilson CB; Edwards MS; Gutin PH; Davis RL; DeArmond SJ
    J Neurosurg; 1986 Mar; 64(3):453-9. PubMed ID: 3950723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological evaluation of intravenous delivery of 5-bromodeoxyuridine to patients with brain tumors.
    Russo A; Gianni L; Kinsella TJ; Klecker RW; Jenkins J; Rowland J; Glatstein E; Mitchell JB; Collins J; Myers C
    Cancer Res; 1984 Apr; 44(4):1702-5. PubMed ID: 6704976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy.
    Dabaja BS; McLaughlin P; Ha CS; Pro B; Meyers CA; Seabrooke LF; Wilder RB; Kyritsis AP; Preti HA; Yung WK; Levin V; Cabanillas F; Cox JD
    Cancer; 2003 Sep; 98(5):1021-8. PubMed ID: 12942571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiosensitization of brain tumor cells with a thymidine analogue (bromouridine).
    Sano K; Hoshino T; Nagai M
    J Neurosurg; 1968 Jun; 28(6):530-8. PubMed ID: 4233585
    [No Abstract]   [Full Text] [Related]  

  • 30. Computerized tomography in the prognosis of malignant cerebral gliomas.
    Murovic J; Turowski K; Wilson CB; Hoshino T; Levin V
    J Neurosurg; 1986 Dec; 65(6):799-806. PubMed ID: 3021932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental and clinical studies of radiosensitizers in brain tumors, with special reference to BUdR-antimetabolite continuous regional infusion-radiation therapy (BAR therapy).
    Sano K; Sato F; Hoshino T; Nagai M
    Neurol Med Chir (Tokyo); 1965; 7():51-72. PubMed ID: 4162242
    [No Abstract]   [Full Text] [Related]  

  • 32. [Chemical modifiers in radiotherapy].
    Nagashima T; Takakura K
    Gan No Rinsho; 1989 Sep; 35(11):1369-71. PubMed ID: 2681875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical rationale for S-phase radiosensitization in human tumors.
    McGinn CJ; Kinsella TJ
    Curr Probl Cancer; 1993; 17(5):273-321. PubMed ID: 8281809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of BAR therapy in a case of malignant glioma with extracranial metastasis].
    Kanno T; Moriyama M; Kagawa M; To T; Ishimori S
    No To Shinkei; 1970 Oct; 22(10):1187-91. PubMed ID: 5536188
    [No Abstract]   [Full Text] [Related]  

  • 35. Prediction of tumor doubling time in recurrent meningiomas. Cell kinetics studies with bromodeoxyuridine labeling.
    Cho KG; Hoshino T; Nagashima T; Murovic JA; Wilson CB
    J Neurosurg; 1986 Dec; 65(6):790-4. PubMed ID: 3772477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bromodeoxyuridine: a comparison of its photosensitizing and radiosensitizing properties.
    Raffel C; Deen DF; Edwards MS
    J Neurosurg; 1988 Sep; 69(3):410-5. PubMed ID: 3404239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuous 28-day iododeoxyuridine infusion and hyperfractionated accelerated radiotherapy for malignant glioma: a phase I clinical study.
    Schulz CA; Mehta MP; Badie B; McGinn CJ; Robins HI; Hayes L; Chappell R; Volkman J; Binger K; Arzoomanian R; Simon K; Alberti D; Feierabend C; Tutsch KD; Kunugi KA; Wilding G; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1107-15. PubMed ID: 15234045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of in vitro bromodeoxyuridine labeling index and DNA aneuploidy with survival or recurrence in brain-tumor patients.
    Nishizaki T; Orita T; Kajiwara K; Ikeda N; Ohshita N; Nakayama H; Furutani Y; Ikeyama Y; Akimura T; Kamiryo T
    J Neurosurg; 1990 Sep; 73(3):396-400. PubMed ID: 1696625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of treatment on long-term survivors with malignant astrocytomas.
    Imperato JP; Paleologos NA; Vick NA
    Ann Neurol; 1990 Dec; 28(6):818-22. PubMed ID: 2178330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A review of cell kinetic studies on brain tumors with special reference to anti-bromodeoxyuridine monoclonal antibody method].
    Nagashima T; Hoshino T
    No Shinkei Geka; 1984 Aug; 12(9):1007-18. PubMed ID: 6390240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.